Sotira Katiri

Learn More
Multidrug-resistant tuberculosis (MDR-TB) is an increasing global problem. The World Health Organization (WHO) guidelines state that all patients suspected of MDR-TB should be given a group 2 injectable agent, usually an aminoglycoside. However, when taken for extended periods, these can cause nephrotoxicity, neurotoxicity and irreversible ototoxicity [1,(More)
  • 1